Landmark 2nd Circ. Decision Means Victory For Pharm Cos.

Law360, New York (December 6, 2012, 2:13 PM EST) -- This week, the United States Court of Appeals for the Second Circuit issued its long-awaited opinion in United States v. Caronia (2d Cir. Dec. 3, 2012), ruling that the First Amendment precludes the U.S. Food and Drug Administration from criminally prosecuting a pharmaceutical sales representative for accurate and truthful promotion of a drug’s unapproved uses.

Tracking the reasoning of the United States Supreme Court in Sorrell v. IMS Health Inc., 131 S. Ct. 2653 (2011), the Second Circuit, in a 2-1 decision, vacated a sales representative’s...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.